Countries differ widely in the types of human biotechnologies they regulate,
the jurisdiction of authority, the nature of enforcement, and other
particulars. One requirement for effective policy is a government agency
responsible for licensing and monitoring research and commercial facilities
that work with human embryos. Frequently cited models are Canada's Assisted Human Reproduction Act and the United Kingdom’s
Human Fertilization and Embryology Authority (HFEA).
China's Big Biotech Bet Starting to Pay Offby Alexandra Harney and Ben Hirschler, ReutersJune 9th, 2015Overall funding for research and development more than quadrupled to $191 billion in 2005-13, allowing China to jump quickly on new technologies, often first developed elsewhere.